Prevalence and outcome of cytomegalovirus-associated pneumonia in relation to human immunodeficiency virus infection

Pediatric Infectious Disease Journal

Volumn 30, Issue 5, 2011, Pages 413-417

  Zampoli, Marco ^a   Morrow, Brenda ^a   Hsiao, Nei Yaun ^a   Whitelaw, Andrew ^a   Zar, Heather J ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

children; cytomegalovirus; HIV; pneumonia

Indexed keywords

AMPICILLIN; ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; GANCICLOVIR; GENTAMICIN; PREDNISONE; VALGANCICLOVIR;

AFRICA; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; VIRUS CULTURE; VIRUS PNEUMONIA;

EID: 79954867571     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e3182065197     Document Type: Article

References (39)

1. Williams AJ, Doung T, McNally LM, et al. Pneumocystis carinii and cytomegalovirus infection in children with vertically acquired HIV infec-tion. AIDS. 2001;15:335-339. (Pubitemid 32163819)
2. Boonsarngsuk V, Sirilak S, Kiattboonsri S. Acute respiratory failure due to Pneumocystis pneumonia: outcome and prognostic factors. Int JInfect Dis. 2009;13:59-66.
3. Chintu C, Mudenda V, Lucas S, et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study Lancet. 2002;360:985-990. (Pubitemid 35284110)
4. Ruffini D, Madhi SA. The high burden of Pneumocystis carinii pneumonia in HIV-1-infected children hospitalized with severe pneumonia. AIDS. 2002;16:105-112. (Pubitemid 34062187)
5. Jeena PM, Coovadia HM, Chrystal V. Pneumocystis carinii and cytomeg-alovirus infections in severely ill, HIV-infected African infants. Ann Trop Paediatr. 1996;16:361-368. (Pubitemid 26417707)
6. Ansari N, Kombe AH, Kenyon TA, et al. Pathology and causes ofdeath in a series of human immunodeficiency virus-positive and negative pediatric referral hospital admissions in Botswana. Pediatr Infect Dis J. 2003;22:43-47. (Pubitemid 36091777)
7. Rabie H, de Boer A, van den Bos S, et al. Children with human immuno-deficiency virus infection admitted to a paediatric intensive care unit in South Africa. J Trop Paediatr. 2007;53:270-273. (Pubitemid 47456815)
8. McNally L, Jeena PM, Gajee K, et al. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study. Lancet. 2007;369:1440-1451. (Pubitemid 46635781)
9. Goussard P, Kling S, Gie RP, et al. CMV pneumonia in HIV-infected ventilated infants. Pediatr Pulmonol. 2010;45:650-655.
10. Kaye S, Miles D, Antoine P, et al. Virological and immunological correlates of mother-to-child transmission ofcytomegalovirus in The Gambia. JInfect Dis. 2008;197:1307-1314. (Pubitemid 351632762)
11. Kovacs A, Schluchter M, Easley K, et al. Cytomegalovirus infection in HIV-1 disease progression in infants born to HIV-1 infected women N Engl J Med. 1999;341:77-84. (Pubitemid 29314238)
12. Nigro G, Krzysztofiak A, Gattinara GC, et al. Rapid progression of HIV disease in children with cytomegalovirus DNAemia. AIDS. 1996;10:1127-1133. (Pubitemid 26283351)
13. Hodson EM, Craig JC, Strippoli GF, et al. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst Rev. 2008;16:CD003774.
14. Mofenson LM, Oleske J, Serchuck L, et al. Treating opportunistic infec-tions among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:S1-S84.
15. Drew WL. Laboratory diagnosis ofcytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis. 2007;20:408-411. (Pubitemid 47026239)
16. Razonable RR, Emery VC; 11th Annual Meeting of the International Herpes Management Forum. Management of CMV infection and disease in transplant patients. Herpes. 2004;11:77-86.
17. Glencross D, Scott LE, Jani IV, et al. CD45-assisted Pan Leucogating for accurate, cost-effective dual-platform CD+4 T-cell enumeration. Cytometry. 2002;50:67-77.
18. Zar HJ, Tannenbaum E, Apolles P, et al. Sputum induction for the diagnosis ofpulmonary tuberculosis in infants and young children in an urban setting in South Africa. Arch Dis Child. 2000;82:305-308. (Pubitemid 30305647)
19. Koumbourlis AC, Kurland G. Non-bronchoscopic bronchoalveolar lavage in mechanically ventilated infants: technique, efficacy and applications. Pediatr Pulmonol. 1993;15:257-263.
20. Adjei AA, Armah HB, Gbagbo F, et al. Seroprevalence ofHHV-8, CMV, and EBV among the general population in Ghana, West Africa. BMC Infect Dis. 2008;188:111.
21. Ghebrekidan H, Ruden U, Cox C, et al. Prevalence of herpes simplex virus types 1 and 2, cytomegalovirus, and varicella-zoster virus infections in Eritrea. J Clin Virol. 1999;12:53-64. (Pubitemid 29085537)
22. Chandwani S, Kaul A, Bebenroth D, et al. Cytomegalovirus infection in human immunodeficiency virus type1-infectedchildren Pediatr Infect Dis J. 1996;15: 310-314. (Pubitemid 26119270)
23. Doyle M, Atkins JT, Rivera-Matos IR. Congenital cytomegalovirus infec-tion in infants infected with human immunodeficiency virus type 1. Pediatr Infect Dis J. 1996;15:1102-1106.
24. Llungman P, Griffiths P, Carlos P. Definitions ofcytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002;34:1094-1097. (Pubitemid 34289682)
25. Mann M, Shelhamer JH, Masur H, et al. Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection. Am J Respir Crit Care. 1997;155:1723-1728. (Pubitemid 27216684)
26. Tamm M, Traenkle P, Brilli B, et al. Pulmonary cytomegalovirus infection inimmunocompromisedpatients. Chest. 2001;119:838-843.
27. Angelici E, Contini C, Sebastiani G, et al. Cytomegalovirus in bronchoal-veolar lavage specimens from patients with AIDS: comparison with anti-genaemia and viraemia. J Med Microbiol. 1996;45:149-152. (Pubitemid 26291486)
28. Uberti-Foppa C, Lillo F, Terreni MR, et al. Cytomegalovirus pneumonia in AIDS patients: value of cytomegalovirus culture from BAL fluid and correlation with lung disease. Chest. 1998;113:919-923. (Pubitemid 28216433)
29. Wohl DA, Zeng D, Stewart P, et al. Cytomegalovirus viraemia and end-organ disease among patients receiving potent antiretroviral therapies. J Aquir Immune Defic Syndr. 2005;38:538-544. (Pubitemid 40524475)
30. Deayton JR, Sabin CA, Johnson MA, et al. Importance ofcytomegalovirus viraemia in risk of disease and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet. 2004;363:2116-2121. (Pubitemid 38844151)
31. Boriskin YS, Sharland M, Dalton R, et al. Viral loads in dual infection with HIV-1 and cytomegalovirus. Arch Dis Child. 1999;80:132-136. (Pubitemid 29119724)
32. Slyker JA, Lohman-Payne BL, John-Stewart GC, et al. Acute cytomegalo-virus infectioninKenyan HIV-infectedinfants. AIDS. 2009;23:2173-2181.
33. Brantsaeter AB, Holberg-Petersen M, Jeansson S, et al. CMV quantitative PCR in the diagnosis of CMV disease in patients with HIV-infection: a retrospective autopsy based study. BMC Infect Dis. 2007;7:127.Available at: http://www.biomedcentral.com/1471-2334/7/. Accessed March2, 2009.
34. Zar HJ, Hanslo D, Tannenbaum E, et al. Aetiology and outcome of pneumonia in human immunodeficiency virus-infected children hospital-ized in South Africa. Acta Paediatr. 2001;90:119-125. (Pubitemid 32222792)
35. Benfield TL, Helweg-Larsen J, Band D, et al. Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia. Chest. 2001;119:844-851. (Pubitemid 32197658)
36. Briel M, Bucher HC, Boscacci R, et al. Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in patients with HIV-infection. Cochrane Database Syst Rev. 2006;3:CD006150.
37. Terblanche AJ, Green RJ, Rheeder P, et al. Adjunctive corticosteroids treatment ofclinical Pneumocystis jirovecii pneumonia in infants less than 18 months of age\a randomised controlled trial. S Afr Med J. 2008;98: 287-290. (Pubitemid 351663211)
38. Madhi SA, Cutland C, Ismail K, et al. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral co-infections in African children with Pneumocystis carinii pneumonia. Clin Infect Dis. 2002;35:1120-1126. (Pubitemid 35239473)
39. Jensen AM, Lundgren JD, Benfield T, et al. Does cytomegalovirus predict poor prognosis in Pneumocystis carinii pneumonia treated with corticoste-roids? A note for caution. Chest. 1995;108:411-414